{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:27:20Z","timestamp":1790476040575,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","funder":[{"name":"Wake Forest Department of Ophthalmology"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To compare features of endogenous endophthalmitis associated with injection drug use (IDU) to endogenous endophthalmitis from other etiologies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The authors retrospectively collected data on patients with endogenous endophthalmitis due to IDU or other causes from three academic tertiary care centers over a six-year period. Differences in presenting characteristics, culture results, treatment, and visual acuity were compared between groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Thirty-eight patients (34%) had IDU-associated endogenous endophthalmitis while 75 patients (67%) had endogenous endophthalmitis from other causes. Compared with patients in the non-IDU group, IDU patients were significantly younger, more frequently male, had longer duration of symptoms at diagnosis, and were less likely to have bilateral disease (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05 for all). Injection drug use patients were less likely to have a systemic infection source identified (29% vs. 71%, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001) or have positive cultures (47% vs. 80%, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). The IDU group was less likely to be admitted to the hospital (71% vs. 92%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.005) and less likely to receive treatment with intravenous antimicrobials (55% vs. 83%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.003). Visual acuity did not significantly differ between groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Endophthalmitis related to IDU presents in younger patients with less comorbidities and frequently without positive cultures or an identifiable systemic source; therefore, a high index of suspicion is needed to identify this disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003898","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T22:00:09Z","timestamp":1690322409000},"page":"1996-2002","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["ENDOGENOUS ENDOPHTHALMITIS ASSOCIATED WITH INJECTION DRUG USE COMPARED WITH OTHER ETIOLOGIES"],"prefix":"10.1097","volume":"43","author":[{"given":"Elizabeth C.","family":"Ciociola","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, University of North Carolina School of Medicine, Chapel Hill, North Carolina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.","family":"Powell","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Wake Forest University School of Medicine, Winston-Salem, North Carolina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza","family":"Barnwell","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Medical University of South Carolina, Charleston, South Carolina; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Zehden","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of North Carolina School of Medicine, Chapel Hill, North Carolina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cason B.","family":"Robbins","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinath","family":"Soundararajan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of North Carolina School of Medicine, Chapel Hill, North Carolina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pali","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice Yang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of North Carolina School of Medicine, Chapel Hill, North Carolina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Fekrat","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Greven","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Wake Forest University School of Medicine, Winston-Salem, North Carolina;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250605","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths\u2014United States, 2000-2014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R2-20250605","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1001\/jama.2017.13358","article-title":"Reframing the opioid epidemic as a national emergency","volume":"318","author":"Gostin","year":"2017","journal-title":"JAMA"},{"key":"R3-20250605","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/infdis\/jiz133","article-title":"Opioids and infectious diseases: a converging public health crisis","volume":"220","author":"Schwetz","year":"2019","journal-title":"J Infect Dis"},{"key":"R4-20250605","doi-asserted-by":"crossref","first-page":"31","DOI":"10.7326\/M18-2124","article-title":"Trends in drug use-associated infective endocarditis and heart valve surgery, 2007 to 2017: a study of statewide discharge data","volume":"170","author":"Schranz","year":"2019","journal-title":"Ann Intern Med"},{"key":"R5-20250605","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jamaophthalmol.2017.0650","article-title":"An outbreak of endogenous fungal endophthalmitis among intravenous drug abusers in New England","volume":"135","author":"Tirpack","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"R6-20250605","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.disamonth.2016.09.005","article-title":"Endophthalmitis","volume":"63","author":"Cunningham","year":"2017","journal-title":"Dis Mon"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1128\/CMR.00113-16","article-title":"Bacterial and fungal endophthalmitis","volume":"30","author":"Durand","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"R8-20250605","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.oret.2016.10.013","article-title":"Intravenous drug use\u2013associated endophthalmitis","volume":"1","author":"Modjtahedi","year":"2017","journal-title":"Ophthalmol Retina"},{"key":"R9-20250605","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1097\/IAE.0000000000000084","article-title":"Endogenous endophthalmitis associated with intravenous drug abuse","volume":"34","author":"Patel","year":"2014","journal-title":"Retina"},{"key":"R10-20250605","doi-asserted-by":"crossref","first-page":"e963","DOI":"10.1111\/aos.14659","article-title":"A novel excel sheet conversion tool from Snellen fraction to LogMAR including 'counting fingers', 'hand movement', 'light perception' and 'no light perception' and focused review of literature of low visual acuity reference values","volume":"99","author":"Moussa","year":"2021","journal-title":"Acta Ophthalmologica"},{"key":"R11-20250605","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.oret.2018.08.009","article-title":"Characteristics and outcomes of endogenous endophthalmitis: eight-year experience at a tertiary care center","volume":"3","author":"Modjtahedi","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"R12-20250605","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0161-6420(13)31255-X","article-title":"Endogenous bacterial endophthalmitis","volume":"101","author":"Okada","year":"1994","journal-title":"Ophthalmology"},{"key":"R13-20250605","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00005792-200303000-00004","article-title":"Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center","volume":"82","author":"Binder","year":"2003","journal-title":"Medicine"},{"key":"R14-20250605","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/eye.2010.145","article-title":"Endogenous endophthalmitis: 10-year experience at a tertiary referral centre","volume":"25","author":"Connell","year":"2011","journal-title":"Eye"},{"key":"R15-20250605","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/ICU.0000000000000606","article-title":"Endogenous endophthalmitis and other ocular manifestations of injection drug use","volume":"30","author":"Luong","year":"2019","journal-title":"Curr Opin Ophthalmol"},{"key":"R16-20250605","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s10792-021-01709-0","article-title":"Endogenous endophthalmitis in patients with intravenous opioid use: demographics and associated comorbidities","volume":"41","author":"Uppuluri","year":"2021","journal-title":"Int Ophthalmol"},{"key":"R17-20250605","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/archinte.167.2.166","article-title":"Injection drug users in the United States, 1979-2002: an aging population","volume":"167","author":"Armstrong","year":"2007","journal-title":"Arch Intern Med"},{"key":"R18-20250605","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajo.2011.06.020","article-title":"Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes","volume":"153","author":"Lingappan","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"R19-20250605","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.survophthal.2014.06.002","article-title":"Systematic review of 342 cases of endogenous bacterial endophthalmitis","volume":"59","author":"Jackson","year":"2014","journal-title":"Surv Ophthalmol"},{"key":"R20-20250605","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1080\/09273948.2019.1642497","article-title":"Endogenous bacterial endophthalmitis: a five-year retrospective review at a tertiary care academic center","volume":"28","author":"Jenkins","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"R21-20250605","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/archopht.1979.01020010036008","article-title":"Candida endophthalmitis after intravenous drug abuse","volume":"97","author":"Aguilar","year":"1979","journal-title":"Arch Ophthalmol"},{"key":"R22-20250605","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.oret.2022.10.013","article-title":"Endogenous endophthalmitis associated with indwelling medical devices","volume":"7","author":"Ciociola","year":"2023","journal-title":"Ophthalmol Retina"},{"key":"R23-20250605","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3928\/1542-8877-19970301-03","article-title":"Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis","volume":"28","author":"Essman","year":"1997","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R24-20250605","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jiac.2015.12.001","article-title":"Study of ocular candidiasis during nine-year period","volume":"22","author":"Tanaka","year":"2016","journal-title":"J Infect Chemother"},{"key":"R25-20250605","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF01964128","article-title":"Possible role of preserved lemon juice in the epidemiology of candida endophtalmitis in heroin addicts","volume":"8","author":"Shankland","year":"1989","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R26-20250605","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/bjo.2006.0108365","article-title":"Lemon juice and Candida endophthalmitis in crack-cocaine misuse","volume":"91","author":"Albini","year":"2007","journal-title":"Br J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003898","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T17:09:41Z","timestamp":1749143381000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003898","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}